Investors are showing renewed interest in biotech stocks as the sector matures and profits increase. JP Morgan this week completed the IPO for one of the world's largest biotech companies, Genentech, raising $1.7bn. Swiss pharmaceuticals company Roche Holdings decided to float its Californian biotech subsidiary, having increased its holding in the company to 100% this June. Roche acquired a 70% stake in Genentech in 1990, and exercised a call option last month to purchase the remaining third of stock. Genentech originally went public in 1980.
July 23, 1999